Castlight Health, inc. (NYSE:CSLT) has been given an average recommendation of “Hold” by the nine analysts that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $4.31.

CSLT has been the topic of a number of research analyst reports. BidaskClub raised shares of Castlight Health, inc. from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Cowen and Company reissued a “market perform” rating and set a $4.50 price objective (up previously from $4.00) on shares of Castlight Health, inc. in a report on Thursday, August 3rd. ValuEngine raised shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a report on Tuesday, August 1st. Dougherty & Co reissued a “buy” rating on shares of Castlight Health, inc. in a report on Thursday, August 17th. Finally, Canaccord Genuity raised shares of Castlight Health, inc. from a “hold” rating to a “buy” rating in a report on Tuesday, October 10th.

In other Castlight Health, inc. news, CFO Mangini Siobhan Nolan sold 28,639 shares of Castlight Health, inc. stock in a transaction dated Friday, August 18th. The shares were sold at an average price of $3.66, for a total transaction of $104,818.74. Following the completion of the transaction, the chief financial officer now owns 41,622 shares in the company, valued at $152,336.52. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO John C. Doyle sold 35,184 shares of Castlight Health, inc. stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $3.65, for a total transaction of $128,421.60. Following the transaction, the chief executive officer now owns 75,639 shares of the company’s stock, valued at approximately $276,082.35. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 208,287 shares of company stock valued at $795,240. 24.38% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Citadel Advisors LLC raised its position in Castlight Health, inc. by 0.7% during the second quarter. Citadel Advisors LLC now owns 105,170 shares of the software maker’s stock worth $437,000 after acquiring an additional 713 shares during the last quarter. Stifel Financial Corp raised its position in Castlight Health, inc. by 4.3% during the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock worth $133,000 after acquiring an additional 1,500 shares during the last quarter. TIAA CREF Investment Management LLC raised its position in Castlight Health, inc. by 2.1% during the first quarter. TIAA CREF Investment Management LLC now owns 108,032 shares of the software maker’s stock worth $394,000 after acquiring an additional 2,210 shares during the last quarter. Edge Wealth Management LLC raised its position in Castlight Health, inc. by 6.5% during the second quarter. Edge Wealth Management LLC now owns 50,050 shares of the software maker’s stock worth $198,000 after acquiring an additional 3,050 shares during the last quarter. Finally, Teachers Advisors LLC raised its position in Castlight Health, inc. by 8.1% during the fourth quarter. Teachers Advisors LLC now owns 62,781 shares of the software maker’s stock worth $311,000 after acquiring an additional 4,717 shares during the last quarter. Institutional investors own 41.29% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Castlight Health, inc. (CSLT) Receives Average Recommendation of “Hold” from Analysts” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark laws. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/18/castlight-health-inc-cslt-receives-average-recommendation-of-hold-from-analysts.html.

Castlight Health, inc. (NYSE:CSLT) opened at 4.35 on Wednesday. Castlight Health, inc. has a 52-week low of $3.05 and a 52-week high of $5.50. The company’s 50 day moving average is $4.14 and its 200 day moving average is $4.03. The firm’s market cap is $572.84 million.

Castlight Health, inc. (NYSE:CSLT) last released its quarterly earnings data on Wednesday, August 2nd. The software maker reported ($0.07) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.02. The firm had revenue of $32.10 million for the quarter, compared to the consensus estimate of $31.14 million. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The firm’s revenue was up 36.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.11) earnings per share. Equities research analysts forecast that Castlight Health, inc. will post ($0.25) EPS for the current fiscal year.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Stock Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related stocks with our FREE daily email newsletter.